Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- Cancer patients who are being treated with a type of therapy that works by boosting the immune system (known as immune checkpoint inhibitor therapy)
- People who have a primary autoimmune or autoinflammatory condition — meaning their immune system attacks their own body — where the condition looks similar to side effects seen with immune checkpoint inhibitor therapy
- Healthy volunteers who do not have any inflammatory conditions and have no history of cancer
Who may not be able to join:
- People who are not able to give their own informed consent to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie Hudson, MD, Jewish General Hospital, McGill University
Phone: 1-514-340-8222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of immune-related adverse events; Biomarkers of irAE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.